Mtap Null Non Small Cell Lung Cancer Clinical Trials

ReadTheTrial indexes 1 studies for Mtap Null Non Small Cell Lung Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Mtap Null Non Small Cell Lung Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Mtap Null Non Small Cell Lung Cancer

A Phase 1/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Anvumetostat in Combination With IDE397 in Subjects With Advanced MTAP-null Solid Tumors

NCT05975073 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Mtap Null Non Small Cell Lung Cancer?

There are 1 clinical trials listed for Mtap Null Non Small Cell Lung Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Mtap Null Non Small Cell Lung Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Mtap Null Non Small Cell Lung Cancer trials in?

Current Mtap Null Non Small Cell Lung Cancer trials are distributed across: Phase 2 (1).

Find More Trials